Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
70 participants
OBSERVATIONAL
2025-01-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasound, Doppler ,and Calprotectin in Necrotizing Enterocolitis Diagnosis
NCT03257553
Transfusion-related Inflammatory Cytokine and Neutrophil Extracellular Trap Quantification in Neonates
NCT01735552
NEC Screening Abdominal Radiograph vs Bowel Ultrasound in Preemies
NCT03963011
Necrotizing Enterocolitis and Bowel Perforation in Very Preterm Infants - Long-term Follow up
NCT06757582
Utility of Bowel Ultrasound in Diagnosing Necrotizing Eneterocolitis in Congenital Heart Disease
NCT03142685
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* in this devastating disease with undetermined etiology. Breast milk feeding, prolonging gestation to avoid prematurity, antenatal steroid, and the use of probiotics/prebiotics are established prevention strategies in NEC
* The hematological abnormalities associated with NEC were first described 25 years ago by Hutter et al.The abnormalities observed in a series of 40 patients with NEC included thrombocytopenia, with
* and without disseminated intravascular coagulation (DIC), neutrophilia or neutropenia, and hemolytic anemia.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neonates with necrotizing enterocolities
Complete blood count
Study haemtological disturbances in neonates with necrotizing enterocolities
Complete blood count
Haemtological disturbances in neonates with necrotizing enterocolities
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Complete blood count
Study haemtological disturbances in neonates with necrotizing enterocolities
Complete blood count
Haemtological disturbances in neonates with necrotizing enterocolities
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Or very low birth weight less than 1500 gram
Exclusion Criteria
* Normal birth weight ,Preterm with early breast feeding or more than 1500 gm
1 Day
30 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mervat maher saad zakhary
Principal investigator
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Necrotizing enterocolities
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.